Light Pharmtech Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
68
- Latest Deal Type
-
Series B
- Investors
-
3
Light Pharmtech General Information
Description
Developer of a novel cancer treatment therapy designed to preserve important human organ functions. The company's therapy uses a photosensitizer that reacts sensitively to the abundant oxygen in the body and the laser light supplied from the outside, enabling physicians to have a replacement surgery for the elderly and for those who cannot be operated on.
Contact Information
Website
www.litepharm.comCorporate Office
- Room 811 E&C Dream Tower
- 41 Digital-ro 31-gil, Guro-gu
- Seoul
- South Korea
Corporate Office
- Room 811 E&C Dream Tower
- 41 Digital-ro 31-gil, Guro-gu
- Seoul
- South Korea
Light Pharmtech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 12-Sep-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 02-Aug-2021 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 09-Feb-2021 | $1.16M | $4.58M | Completed | Generating Revenue | |
| 1. Angel (individual) | 02-Dec-2019 | $3.42M | $3.42M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Light Pharmtech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Light Pharmtech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Light Pharmtech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Inventera | Corporation | Minority | ||
| IMM Investment | Asset Manager | Minority | ||
| Solidus Investment | Venture Capital | Minority |
Light Pharmtech Investments (2)
Light Pharmtech’s most recent deal was a Corporate Asset Purchase with Shinchang Enterprise (Factory Land in Pyeongtaek, South Korea) for . The deal was made on 29-Apr-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shinchang Enterprise (Factory Land in Pyeongtaek, South Korea) | 29-Apr-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Nature & Human GP (Portfolio of Land and Building in Pyeongtaek, South Korea) | 29-Mar-2020 | Corporate Asset Purchase | Buildings and Property |
Light Pharmtech FAQs
-
When was Light Pharmtech founded?
Light Pharmtech was founded in 2005.
-
Where is Light Pharmtech headquartered?
Light Pharmtech is headquartered in Seoul, South Korea.
-
What is the size of Light Pharmtech?
Light Pharmtech has 68 total employees.
-
What industry is Light Pharmtech in?
Light Pharmtech’s primary industry is Pharmaceuticals.
-
Is Light Pharmtech a private or public company?
Light Pharmtech is a Private company.
-
What is Light Pharmtech’s current revenue?
The current revenue for Light Pharmtech is .
-
How much funding has Light Pharmtech raised over time?
Light Pharmtech has raised $6.33M.
-
Who are Light Pharmtech’s investors?
Inventera, IMM Investment, and Solidus Investment have invested in Light Pharmtech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
